PEP:PYTHPEPSICO INC / US DOLLAR Analysis
Data as of 2026-06-12 - not real-time
$144.28
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
PepsiCo trades at $144.28, sitting just below its 20‑day SMA (145.35) but above the 50‑day (151.20) and 200‑day (150.32) averages, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 43 suggests the stock is not yet oversold, while the MACD shows a bullish crossover (histogram +0.30) that could support a modest rebound toward the $152.57 resistance level. Revenue grew 8.5% YoY in Q1 2026 with a solid 54% gross margin and a 44% ROE, underscoring strong operating performance. However, the DCF fair value of $89.08 is far below the current price, and the forward PE of 15.8 implies investors are paying a premium for growth expectations. The dividend yield of 4.12% and a payout ratio of 89% are attractive, but sustainability hinges on the robust free cash flow of $8.75 B. Overall, the stock appears overvalued relative to intrinsic models but benefits from a defensive consumer‑staples positioning, stable volume, and a low beta, making it a resilient holding in a volatile market.
The consensus analyst outlook is “hold” with a median target of $173, suggesting upside potential of roughly 18% from today’s price. With moderate 30‑day volatility (20%) and a max drawdown of 17%, risk is contained, especially given PepsiCo’s global footprint and diversified product mix. The high dividend yield combined with strong cash generation supports a long‑term income play, while the forward earnings multiple and revenue growth justify a buy stance for medium‑ to long‑term investors.
The consensus analyst outlook is “hold” with a median target of $173, suggesting upside potential of roughly 18% from today’s price. With moderate 30‑day volatility (20%) and a max drawdown of 17%, risk is contained, especially given PepsiCo’s global footprint and diversified product mix. The high dividend yield combined with strong cash generation supports a long‑term income play, while the forward earnings multiple and revenue growth justify a buy stance for medium‑ to long‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support at $139.26
- Neutral trend direction and RSI around 43
- Bullish MACD signal but limited upside to resistance $152.57
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst median target $173 indicating ~18% upside
- Forward PE 15.8 suggests reasonable valuation relative to growth
- Strong revenue growth (8.5% YoY) and high free cash flow
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Defensive consumer‑staples sector with low beta
- High dividend yield (4.12%) and solid ROE (44%)
- Robust brand portfolio and global diversification
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin9.15%
P/E Ratio22.6
ROE43.88%
ROA9.09%
Debt/Equity244.84
P/B Ratio9.2
Op. Cash Flow$13.1B
Free Cash Flow$8.7B
Technical Analysis
TrendNeutral
RSI43.2
Support$139.26
Resistance$152.57
MA 20$145.35
MA 50$151.20
MA 200$150.32
MACDBullish
VolumeStable
Fear & Greed Index88.66
Valuation
Fair Value$89.08
Target Price$170.43
Upside/Downside18.12%
GradeOvervalued
TypeBlend
Dividend Yield4.12%
Risk Assessment
Beta-0.11
Volatility20.19%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.